Literature DB >> 16762808

Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?

Walter Paulus1, Eike D Schomburg.   

Abstract

The pathophysiology of restless legs syndrome (RLS) is incompletely understood. L-DOPA, as the precursor of dopamine, as well as dopamine agonists, plays an essential role in the treatment of RLS leading to the assumption of a key role of dopamine function in the pathophysiology of RLS. Periodic limb movements in sleep are a key feature of RLS. They are generated in the spinal cord. Here we review RLS phenomenology on the basis of known dopaminergic influence on spinal control, which has been studied a great deal in recent decades in animals. In particular, we propose that the differential effects of l-DOPA and opioids on early and late flexor reflexes may be linked to the phenomenon of augmentation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762808     DOI: 10.1016/j.smrv.2006.01.004

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  9 in total

Review 1.  Drug-induced sleep: theoretical and practical considerations.

Authors:  Jeffrey M Ellenbogen; Edward F Pace-Schott
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

Review 2.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

3.  Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.

Authors:  Birgit Högl; Walter Paulus; Peter Clarenbach; Claudia Trenkwalder
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

4.  Refractory restless legs syndrome likely caused by olanzapine.

Authors:  Imran Khalid; Lopa Rana; Tabindeh J Khalid; Timothy Roehrs
Journal:  J Clin Sleep Med       Date:  2009-02-15       Impact factor: 4.062

5.  Microstructure of the Midbrain and Cervical Spinal Cord in Idiopathic Restless Legs Syndrome: A Diffusion Tensor Imaging Study.

Authors:  Klaas Lindemann; Hans-Peter Müller; Albert C Ludolph; Magdolna Hornyak; Jan Kassubek
Journal:  Sleep       Date:  2016-02-01       Impact factor: 5.849

Review 6.  Dopamine agonists for restless legs syndrome.

Authors:  Hanna Scholz; Claudia Trenkwalder; Ralf Kohnen; Dieter Riemann; Levente Kriston; Magdolna Hornyak
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

7.  Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome.

Authors:  Valerie Voon; Andrea Schoerling; Sascha Wenzel; Vindhya Ekanayake; Julia Reiff; Claudia Trenkwalder; Friederike Sixel-Döring
Journal:  BMC Neurol       Date:  2011-09-28       Impact factor: 2.474

8.  The effects of long-term dopaminergic treatment on locomotor behavior in rats.

Authors:  Welinton Alessandro Oliveira de Almeida; Andrea Maculano Esteves; Canuto Leite de Almeida-Júnior; Kil Sun Lee; Miriam Kannebley Frank; Melise Oliveira Mariano; Roberto Frussa-Filho; Sergio Tufik; Marco Tulio de Mello
Journal:  Sleep Sci       Date:  2014-11-12

9.  Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome.

Authors:  Samantha Meneely; Mai-Lynne Dinkins; Miki Kassai; Shangru Lyu; Yuning Liu; Chien-Te Lin; Kori Brewer; Yuqing Li; Stefan Clemens
Journal:  Front Behav Neurosci       Date:  2018-09-04       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.